Greater Worcester

Commerce Bank and Habitat for Humanity MetroWest/Greater Worcester have been awarded a $25,000 grant by the Federal Home Loan Bank of Boston, to help fund the rehabilitation of a single-family home in Worcester for a wounded veteran and his or her family.

UMass Medical School in Worcester will collaborate with Lysogene, a French biotechnology company, and Auburn University in Alabama, to develop pre-clinical studies of a rare disorder that causes neurological impairment, Lysogene announced.

The Worcester Regional Chamber of Commerce has partnered with the Regional Environmental Council to study the feasibility of creating a food hub in Worcester.

Paying for extras on plane trips out of Worcester is going to get a bit easier for those with an iPhone as Jet Blue announced Tuesday that it will be the first major domestic carrier in the U.S. to accept Apple Pay during flights.

If you thought you were paying more at the pumps within the last several days, you weren't imagining it. Average retail gasoline prices rose 8.4 cents per gallon in the past week, according to GasBuddy.com's latest survey.

Worcester Polytechnic Institute is expanding its reach in Panama and offering more learning experiences for its students in the Central American republic, the school announced Monday.

Amid a growing need for more space and facilities, Worcester's colleges have undertaken multi-million-dollar projects that are...

The Worcester Regional Transit Authority has secured a $1 million federal grant to boost the reliability of its electric buses while reducing its carbon footprint, U.S. Rep. James McGovern's office announced Thursday.

Worcester-based Hanover Insurance Group reported a profit of $89.9 million for the fourth quarter, ending what president and CEO Frederick H. Eppinger called “a strong year for our company.”

Preeclampsia is a leading cause of maternal and infant death worldwide, though the causes are poorly understood, and treatment options are limited. When an expectant mother develops the disease – which causes high blood pressure, swelling, headache, vision changes and seizures – the normal course of action is to deliver the baby as soon as possible to avoid the potential death of both mother and baby. But when it occurs too early in a pregnancy, that remedy is surrounded by health risks for the baby that could result in life-long problems. It's a conundrum rEVO Biologics of Framingham is trying to solve. The biopharmaceutical company, which is focused on developing and commercializing treatments for patients with rare, life-threatening diseases, began clinical trials last summer on a drug that may allow women to prolong their pregnancies than what available medicine allows.